OneOme, co-founded by Mayo Clinic, is a leader in providing evidence-based pharmacogenetic solutions to healthcare organizations around the world.
Combined with an in-house CLIA-certified, CAP-accredited lab, OneOme's RightMed Test provides genetic insights that providers and pharmacists can use to
make more informed medication decisions for their patients.
At OneOme, we have a vision of a world where medications are optimized to each patient's genetic profile. We are working to achieve this by fulfilling our mission of enabling healthcare teams with evidence-based pharmacogenomic testing and analytics that help improve outcomes and reduce costs through more personalized medication decisions.